The Company has now received the renewed GMP (Good Manufacturing Practices) certificate thereby confirming the successful closure of the inspection. The company in August 2020 had also announced successful completion of the UK MHRA inspection at the site.
The Puducherry facility caters to the U.S., other regulated markets and institutional businesses and has capabilities to produce finished dosage formulation products across multiple dosage formats.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content